Clinical Research Directory
Browse clinical research sites, groups, and studies.
HEFTME System for Adjuvant Therapeutic Selection of Locally Advanced UTUC Postoperatively：A Perspective Cohort Study
Sponsor: Peking University First Hospital
Summary
This multicenter, real-world study introduces a novel Hematoxylin-eosin staining(H\&E)-based four tumor microenvironment (TME) system (HEFTME system) assisting in prognostic prediction and precise adjuvant treatment selection for laUTUC postoperatively.
Official title: Hematoxylin-eosin Staining-based Tumor Microenvironment Subtype System Adjuvant Therapeutic Selection for Locally Advanced Upper Tract Urothelial Carcinoma After Radical Surgery：A Perspective Cohort Study
Key Details
Gender
All
Age Range
18 Years - 80 Years
Study Type
OBSERVATIONAL
Enrollment
200
Start Date
2025-02-01
Completion Date
2030-01-01
Last Updated
2025-01-29
Healthy Volunteers
No
Conditions
Interventions
Chemotherapy
Gemicitabin and cisplatin
Immunotherapy
PD-1/PD-L1
ADC
ADC drug like RC48
Chemotherapy combined with immunotherapy
Chemotherapy combined with immunotherapy